MBX Biosciences, Inc. (MBX) has 23 open-market insider trades by 18 insiders since 2024. Over the last six months insiders net sold $49K. The most active filer is P. Kent Hawryluk, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Carl L. Gordon | Dir10% Owner | — | 2 | $14.7M | 2025-02-18 |
| Tiba Aynechi | Dir | — | 1 | $12.0M | 2024-09-16 |
| FHMLS X, L.P. via Patrick J. Heron | Dir10% Owner | — | 1 | $12.0M | 2025-09-26 |
| Patrick J. Heron | Dir10% Owner | — | 1 | $10.0M | 2024-09-16 |
| Forest Baskett | 10% Owner | — | 1 | $8.0M | 2024-09-16 |
| Mohamad Makhzoumi | 10% Owner | — | 1 | $8.0M | 2024-09-16 |
| Paul Edward Walker | 10% Owner | — | 1 | $8.0M | 2024-09-16 |
| Carmen Chang | 10% Owner | — | 1 | $8.0M | 2024-09-16 |
| Edward T. Mathers | Dir10% Owner | — | 1 | $8.0M | 2024-09-16 |
| Rick Yang | 10% Owner | — | 1 | $8.0M | 2024-09-16 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Salomon Azoulay | — | Sell | $24K | 2026-08-04 |
| Salomon Azoulay | — | Sell | $2.7M | 2026-05-08 |
| Salomon Azoulay | — | Sell | $7K | 2026-05-06 |
| P. Kent Hawryluk | CEO & President | Sell | $18K | 2026-05-06 |
| P. Kent Hawryluk | CEO & President | Buy | $526K | 2026-03-13 |
| P. Kent Hawryluk | CEO & President | Buy | $273K | 2025-10-20 |
Companies that share insiders with MBX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Steven L. Hoerter | Director | Buy | $265K | 2025-10-17 |
| FHMLS X, L.P. | Director & 10% Owner | Buy | $12.0M | 2025-09-26 |
| Ora H. Pescovitz | Director | Buy | $45K | 2025-04-08 |
| OrbiMed Genesis GP LLC | Director & 10% | Buy | $710K | 2025-02-14 |
| Carl L. Gordon | Director & 10% Owner | Buy | $2.7M | 2025-02-14 |
| P. Kent Hawryluk | CEO & President | Buy | $535K | 2025-02-04 |
| Patrick J. Heron | Director & 10% Owner | Buy | $10.0M | 2024-09-16 |
| Rick Yang | 10% Owner | Buy | $8.0M | 2024-09-16 |
| Tiba Aynechi | Director | Buy | $12.0M | 2024-09-16 |